| Literature DB >> 30831436 |
John Le1, Eric Perez1, Leah Nemzow1, Feng Gong2.
Abstract
DNA damage response (DDR) serves as an integrated cellular network to detect cellular stress and react by activating pathways responsible for halting cell cycle progression, stimulating DNA damage repair, and initiating apoptosis. Efficient DDR protects cells from genomic instability while defective DDR can allow DNA lesions to go unrepaired, causing permanent mutations that will affect future generations of cells and possibly cause disease conditions such as cancer. Therefore, DDR mechanisms must be tightly regulated in order to ensure organismal health and viability. One major way of DDR regulation is ubiquitination, which has been long known to control DDR protein localization, activity, and stability. The reversal of this process, deubiquitination, has more recently come to the forefront of DDR research as an important new angle in ubiquitin-mediated regulation of DDR. As such, deubiquitinases have emerged as key factors in DDR. Importantly, deubiquitinases are attractive small-molecule drug targets due to their well-defined catalytic residues that provide a promising avenue for developing new cancer therapeutics. This review focuses on the emerging roles of deubiquitinases in various DNA repair pathways.Entities:
Keywords: DNA damage response; DNA repair; Deubiquitination; Post-transcriptional modification
Mesh:
Substances:
Year: 2019 PMID: 30831436 PMCID: PMC6561784 DOI: 10.1016/j.dnarep.2019.02.011
Source DB: PubMed Journal: DNA Repair (Amst) ISSN: 1568-7856